Organ-on-Chip technology simulates the functions of a specific human organ or multiple organs on a small chip. This enables researchers to test drug efficacy and toxicity in an environment that closely mimics the human body.
Traditional drug testing methods using animal models or human clinical trials have limitations in terms of accuracy and ethical concerns. Organ-on-Chip technology addresses these issues by providing a more reliable, efficient, and ethically sound alternative for personalized drug testing.
By integrating microfluidic channels with living cells, these chips can replicate physiological conditions and cell-to-cell interactions found within actual organs. Drugs are then administered through the fluidic system to observe their effects on the organ-specific tissues.
Manufacturing involves the precise alignment and integration of microfluidic channels with living cells from various tissues. The process requires cleanroom conditions to maintain sterility and advanced bioprinting or microfabrication techniques.
Cells are isolated, cultured, and then encapsulated in hydrogels or other bio-compatible materials before being placed into the microfluidic channels. These channels are designed to mimic the structural and functional characteristics of actual organs.
Curated names only — none are invented. Use the link to find more.
Cost drivers only — no verified dollar figures are shown. Check live sources for prices.
Illustrative — search real, dated examples rather than trusting a generated story.
Live searches — we don't list papers we can't verify.
Live patent searches — filings are never listed from memory.
Verify against primary sources only.
Source: curated technology intelligence stream with tracked references.